Status:
COMPLETED
Full Automaticity and Remote Follow-up
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Collaborating Sponsors:
Medtronic
Conditions:
Tachyarrhythmia
Eligibility:
All Genders
18+ years
Brief Summary
With the expansion of Sudden Cardiac Death (SCD) primary prevention indications, the number of Implantable Cardioverter Defibrillators (ICD) implants has increased significantly in the recent years. T...
Eligibility Criteria
Inclusion
- Patient older than 18,
- Patient implanted with a fully automatic ICD and remotely followed-up,
- Patient geographically stable and able to attend FU at investigative site
- Patient who signed a data release authorization form,
Exclusion
- Patient whose mental or physical capacity impedes to give an informed data release authorization,
- Patient already enrolled in a clinical study whose procedures may interfere with the results of the present study,
- Patients in New York Heart Association (NYHA) class IV
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
354 Patients enrolled
Trial Details
Trial ID
NCT01526629
Start Date
May 1 2011
End Date
March 1 2015
Last Update
July 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Montfermeil
Montfermeil, France, 93370